Literature DB >> 708377

Effect of heparin on thrombin inactivation by antithrombin-III.

R Machovich, P Arányi.   

Abstract

The inactivation of thrombin by heat and by its physiological inhibitor, antithrombin-III, shows quite different dependence on heparin concentration. Heparin at 250 microgram/ml protects thrombin against heat inactivation, and thrombin behaves heterogeneously in this reaction. In the absence of heparin, the thermodynamic activation parameters change with temperature (deltaH+ = 733 kJ/mol and 210 kJ/mol at 50 and 58 degrees C respectively). When heparin is present, heat inactivation of the protected thrombin species proceeds with deltaH+ = 88 kJ/mol and is independent of temperature in the same range. On the other hand, heparin at 0.125-2.5 microgram/ml accelerates the thrombin-antithrombin-III reaction. Thrombin does not show heterogeneity in this reaction and the time courses at any heparin concentration and any temperature between 0 and 37 degrees C appear to follow first-order kinetics. Activation enthalpy is independent of heparin concentration or temperature, deltaH+ = 82-101 kJ/mol, varying slightly with antithrombin-III concentration and thrombin specific activity. Heparin seems to exert its effect by increasing activation entropy. On the basis of these data we suggest a mechanism of action of heparin in the thrombin-antithrombin-III reaction which accounts for all the important features of the latter and seems to unify the different hypotheses that have been advanced.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708377      PMCID: PMC1185853          DOI: 10.1042/bj1730869

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  The inactivation of thrombin and plasmin by antithrombin III in the presence of sepharose-heparin.

Authors:  M W Hatton; E Regoeczi
Journal:  Thromb Res       Date:  1977-05       Impact factor: 3.944

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Remarks on the interaction of thrombim and heparin.

Authors:  P Arányi; J Batke; R Machovich
Journal:  Arch Biochem Biophys       Date:  1977-06       Impact factor: 4.013

4.  Effect of calcium ion on the interaction between thrombin and heparin. Thermal denaturation.

Authors:  R Machovich; P Arányi
Journal:  Thromb Haemost       Date:  1977-10-31       Impact factor: 5.249

5.  Small-angle x-ray scattering studies on human antithrombin III and its complex with heparin.

Authors:  B Furugren; L O Andersson; R Einarsson
Journal:  Arch Biochem Biophys       Date:  1977-01-30       Impact factor: 4.013

6.  Decreased heparin sensitivity of cycholhexanedione-modified thrombin.

Authors:  R Machovich; M Staub; L Patthy
Journal:  Eur J Biochem       Date:  1978-02

7.  Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin III.

Authors:  I Danishefsky; M Ahrens; S Klein
Journal:  Biochim Biophys Acta       Date:  1977-06-23

8.  Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.

Authors:  R Einarsson; L O Andersson
Journal:  Biochim Biophys Acta       Date:  1977-01-25

9.  Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.

Authors:  D Collen; J Schetz; F de Cock; E Holmer; M Verstraete
Journal:  Eur J Clin Invest       Date:  1977-02       Impact factor: 4.686

10.  Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor.

Authors:  R Machovich; A Borsodi; G Blaskó; S A Orakzai
Journal:  Biochem J       Date:  1977-11-01       Impact factor: 3.857

View more
  13 in total

1.  Fluorescent reporters of thrombin, heparin cofactor II, and heparin binding in a ternary complex.

Authors:  Ingrid M Verhamme
Journal:  Anal Biochem       Date:  2011-12-06       Impact factor: 3.365

Review 2.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

3.  The nature of the phosphate inhibitor complex of sulphite oxidase from electron-paramagnetic-resonance studies using oxygen-17.

Authors:  S Gutteridge; M T Lamy; R C Bray
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

Review 4.  Mechanism of the anticoagulant action of heparin.

Authors:  I Björk; U Lindahl
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

5.  A comprehensive mathematical model for three-body binding equilibria.

Authors:  Eugene F Douglass; Chad J Miller; Gerson Sparer; Harold Shapiro; David A Spiegel
Journal:  J Am Chem Soc       Date:  2013-04-16       Impact factor: 15.419

6.  Kinetic analysis of the heparin-enhanced plasmin--antithrombin III reaction. Apparent catalytic role of heparin.

Authors:  R Machovich; P I Bauer; P Arányi; E Kecskés; K G Büki; I Horváth
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

7.  Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.

Authors:  D A Lane; J Denton; A M Flynn; L Thunberg; U Lindahl
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

8.  The relative molecular mass dependence of the anti-factor Xa properties of heparin.

Authors:  V Ellis; M F Scully; V V Kakkar
Journal:  Biochem J       Date:  1986-09-01       Impact factor: 3.857

9.  The acceleration of the inhibition of platelet prothrombinase complex by heparin.

Authors:  V Ellis; M F Scully; V V Kakkar
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

Review 10.  Clinical pharmacokinetics of heparin.

Authors:  J W Estes
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.